.FDA rejects experimental MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Decreases to Authorize MDMA Treatment, Finding Additional Research Study The Nyc TimesFDA Rejects Ecstasy-Based Medicine The Exchange JournalFDA declines to authorize unfamiliar MDMA treatment to handle post-traumatic stress disorder, with request for additional hearing data CNNFDA denies to begin with experimental to handle PTSD, asking for additional research study The Washington Message.